中国实用眼科杂志
中國實用眼科雜誌
중국실용안과잡지
CHINESE JOURNAL OF PRACTICAL OPHTHALMOLOGY
2013年
12期
1573-1575
,共3页
Verisyse%有晶状体眼人工晶状体植入
Verisyse%有晶狀體眼人工晶狀體植入
Verisyse%유정상체안인공정상체식입
Verisyse%Intraocular lens implantation for phakic eye
目的 通过对比分析有晶状体眼植入人工晶状体治疗高度近视患者术前及术后至少5年以上术眼的视力、视功能、角膜内皮计数、并发症等结果,评价该治疗方法的长期有效性及安全性.方法 对2005～2007年在大连医科大学附属第一医院眼科就诊并随访超过5年的有晶状体眼人工晶状体植入治疗高度近视患者10例18只眼,进行裸眼视力,最佳矫正视力,调节幅度,眼压,角膜内皮细胞计数等指标的检测分析.结果 术后裸眼视力(UCVA) 0.73±0.27,术后最佳矫正视力(BCVA)0.94 ±0.21,15只眼(占83.3％) BCVA较术前提高1行以上,术后调节幅度(7.5±1.72)D,均较术前大幅提高.术后5年角膜内皮计数(3106.61 ±430.29)个/mm2,较术前有所减少.术后眼压(14.57 ±2.50)mm Hg.并发症:2只眼分别于术后4年半和6年人工晶状体脱位,取出晶状体后,BCVA未丢失,1只眼术后2年视网膜脱离,行手术视网膜复位并且保留了原人工晶状体.结论 Verisyse人工晶状体植入治疗高度近视长期效果观察,结果显示尚安全有效,更多的病例和更长期的结果尚需观察.
目的 通過對比分析有晶狀體眼植入人工晶狀體治療高度近視患者術前及術後至少5年以上術眼的視力、視功能、角膜內皮計數、併髮癥等結果,評價該治療方法的長期有效性及安全性.方法 對2005～2007年在大連醫科大學附屬第一醫院眼科就診併隨訪超過5年的有晶狀體眼人工晶狀體植入治療高度近視患者10例18隻眼,進行裸眼視力,最佳矯正視力,調節幅度,眼壓,角膜內皮細胞計數等指標的檢測分析.結果 術後裸眼視力(UCVA) 0.73±0.27,術後最佳矯正視力(BCVA)0.94 ±0.21,15隻眼(佔83.3％) BCVA較術前提高1行以上,術後調節幅度(7.5±1.72)D,均較術前大幅提高.術後5年角膜內皮計數(3106.61 ±430.29)箇/mm2,較術前有所減少.術後眼壓(14.57 ±2.50)mm Hg.併髮癥:2隻眼分彆于術後4年半和6年人工晶狀體脫位,取齣晶狀體後,BCVA未丟失,1隻眼術後2年視網膜脫離,行手術視網膜複位併且保留瞭原人工晶狀體.結論 Verisyse人工晶狀體植入治療高度近視長期效果觀察,結果顯示尚安全有效,更多的病例和更長期的結果尚需觀察.
목적 통과대비분석유정상체안식입인공정상체치료고도근시환자술전급술후지소5년이상술안적시력、시공능、각막내피계수、병발증등결과,평개해치료방법적장기유효성급안전성.방법 대2005～2007년재대련의과대학부속제일의원안과취진병수방초과5년적유정상체안인공정상체식입치료고도근시환자10례18지안,진행라안시력,최가교정시력,조절폭도,안압,각막내피세포계수등지표적검측분석.결과 술후라안시력(UCVA) 0.73±0.27,술후최가교정시력(BCVA)0.94 ±0.21,15지안(점83.3％) BCVA교술전제고1행이상,술후조절폭도(7.5±1.72)D,균교술전대폭제고.술후5년각막내피계수(3106.61 ±430.29)개/mm2,교술전유소감소.술후안압(14.57 ±2.50)mm Hg.병발증:2지안분별우술후4년반화6년인공정상체탈위,취출정상체후,BCVA미주실,1지안술후2년시망막탈리,행수술시망막복위병차보류료원인공정상체.결론 Verisyse인공정상체식입치료고도근시장기효과관찰,결과현시상안전유효,경다적병례화경장기적결과상수관찰.
Objective To evaluate the safety and efficacy of implantation Verisyse intraocular lens for high myopia,through comparing visual acuity,visual function,endothelium number,complications of postoperation.Methods Ten cases (18 eyes) received Verisyse IOL at least 5 years were collected,and the UCVA,BCVA,amplitude of accommodation,IOP,mean count of endothelium were checked for them.Results Post-op UCVA:0.73±0.27; post-op BCVA:0.94±0.21; 15 eyes (83.3％) BCVA were improved one line or more than pre-op; post-op amplitude of accommodation:7.5D± 1.72D,all these were improved than that of pre-op.Post-op mean count of endothelium:3106.61 ± 430.29/mm2,which decreased compared with that of pre-op.Post-op IOP:14.57±2.50mmHg.Complications Verisyse PIOL dislocated with 2 eyes had been removed,and BCVA wasn't lost.Another eye suffered retinal detachment,after operation the retina was reconstructed.Conclusions The long period observation of Verisyse PIOL implantation for high myopia is effective and safety.More cases and longer time follow-up should be confirmed further.
